Skip to content

Direct Bilirubin

by Randox Laboratories Limited

510(k) K152343

Direct Bilirubin is a medical device (FDA Class II; FDA product code JFM, Enzymatic Method, Bilirubin) made by Randox Laboratories Limited, cleared under FDA 510(k) K152343 on 16 Feb 2016, active as of 11 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 11 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 11 Oct 2026.

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK152343 Date16 Feb 2016ClearedStatusActive

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
JFM
Device class
Class II
Regulation
21 CFR Part 862.1110
Advisory committee
Clinical Chemistry
FDA decision
SESE Substantially Equivalent

Devices cleared under K152343

2 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K152343
UDI-DISize and differences
D BIL BR8308
Randox Laboratories, Ltd.
BR8308 / BR830805055273208313 —On the market
D BIL BR9765
Randox Laboratories, Ltd.
BR9765 / BR976505055273208320 —On the market

Similar devices

Other devices filed under FDA product code JFM (Enzymatic Method, Bilirubin).

Other devices from Randox Laboratories Limited

See all devices from Randox Laboratories Limited →